Response to the commentary on “Definitive IMRT in older men with high-risk prostate cancer: additional considerations and future directions” by Bin Cheng, Yuekun Fang, and Shengyi Chen

IF 5.3 1区医学 Q1 ONCOLOGY Radiotherapy and Oncology Pub Date : 2025-03-14 DOI:10.1016/j.radonc.2025.110844

Taek-Keun Nam, Yong-Hyub Kim, Jae-Uk Jeong, “Comparison of definitive radiotherapy outcomes between younger and older patients with high- or very-high-risk prostate cancer”

引用次数: 0

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

回应 Bin Cheng、Yuekun Fang 和 Shengyi Chen 关于 "高风险前列腺癌老年男性患者的确定性 IMRT：其他考虑因素和未来方向 "的评论。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文去求助

来源期刊

Radiotherapy and Oncology 医学-核医学

CiteScore

10.30

自引率

10.50%

发文量

2445

审稿时长

45 days

期刊介绍： Radiotherapy and Oncology publishes papers describing original research as well as review articles. It covers areas of interest relating to radiation oncology. This includes: clinical radiotherapy, combined modality treatment, translational studies, epidemiological outcomes, imaging, dosimetry, and radiation therapy planning, experimental work in radiobiology, chemobiology, hyperthermia and tumour biology, as well as data science in radiation oncology and physics aspects relevant to oncology.Papers on more general aspects of interest to the radiation oncologist including chemotherapy, surgery and immunology are also published.

期刊最新文献

Development and external validation of an MRI radiomics-based machine learning model to predict tumour recurrence in brain metastases treated with Gamma Knife radiosurgery. How can a radiation oncology society support its members and the community to help reduce the carbon footprint of radiation oncology? Same risk, different scales: outcome calibration and contour provenance in a 3D deep NTCP for dysphagia? Development of the first prediction model for radiation-induced contrast enhancement after proton therapy for posterior fossa tumours in paediatric patients Are the CTV-to-PTV margins currently used in online adaptive radiotherapy for prostate cancer too large? The impact of the distribution of microscopic disease on treatment margin requirements